Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen

Toshiro Ono(Memorial Sloan Kettering Cancer Center), Takushi Kurashige(Memorial Sloan Kettering Cancer Center), Naoki Harada(Memorial Sloan Kettering Cancer Center), Yuji Noguchi(Memorial Sloan Kettering Cancer Center), Takashi Saika(Memorial Sloan Kettering Cancer Center), Norio Niikawa(Memorial Sloan Kettering Cancer Center), Motoi Aoe(Memorial Sloan Kettering Cancer Center), Shinichiro Nakamura(Memorial Sloan Kettering Cancer Center), Toshihiro Higashi(Memorial Sloan Kettering Cancer Center), Akio Hiraki(Memorial Sloan Kettering Cancer Center), Hisashi Wada(Memorial Sloan Kettering Cancer Center), Hiromi Kumon(Memorial Sloan Kettering Cancer Center), Lloyd J. Old(Memorial Sloan Kettering Cancer Center), Eiichi Nakayama(Memorial Sloan Kettering Cancer Center)
Proceedings of the National Academy of Sciences
March 13, 2001
Cited by 109Open Access
Full Text

Abstract

Serological expression cloning of antigens eliciting a humoral immune response to a syngeneic mouse sarcoma identified pem (mouse placenta and embryonic expression gene) as a new member of the cancer/testis family. To identify the human homologue of pem, mouse pem sequences and pem-related expressed sequence tags from human testis were used as PCR primers for amplification using human testis cDNA. However, rather than pem, another gene, designated OY-TES-1, was isolated and found to be the human homologue of proacrosin binding protein sp32 precursor originally identified in mouse, guinea pig, and pig. OY-TES-1 maps to chromosome 12p12-p13 and contains 10 exons. Southern blot analysis suggests the presence of two OY-TES-1-related genes in the human genome. In normal tissues, OY-TES-1 mRNA was expressed only in testis, whereas in malignant tissues, a variable proportion of a wide array of cancers, including bladder, breast, lung, liver, and colon cancers, expressed OY-TES-1. Serological survey of 362 cancer patients with a range of different cancers showed antibody to OY-TES-1 in 25 patients. No OY-TES-1 sera reactivity was found in 20 normal individuals. These findings indicate that OY-TES-1 is an additional member of the cancer/testis family of antigens and that OY-TES-1 is immunogenic in humans.


Related Papers

No related papers found

Powered by citation graph analysis